Key result
Treatment with 2% nitroglycerine ointment yielded optimal results with no adverse events in three preterm neonates with ischemic limb lesions.
Why the study?
Ischemic lesions occur in neonatal intensive care units secondary to routine procedures or medications, but a defined protocol for treatment with nitroglycerine ointment is currently lacking.
Does 2% nitroglycerine ointment improve outcomes and is it safe in preterm neonates with ischemic limb lesions?
Case Report (n=3)
Yes
Does 2% nitroglycerine ointment improve outcomes and is it safe in preterm neonates with ischemic limb lesions?
Topical 2% nitroglycerine ointment may be a safe and effective treatment for ischemic limb lesions in preterm neonates, highlighting the need for standardized protocols.
May support use in preterm neonates with ischemic limb lesions; hypothesis-generating case data requiring prospective trials.
Although rare, ischemic lesions in neonates may occur in Neonatal Intensive Care Units (NICUs) secondary to routine procedures and/or medicaments. We present double-center case series, reporting three preterm neonates with ischemic lesions following cardiac arrest and radial blood sampling. The overall outcome after treatment with 2% nitroglycerine (NTG) ointment showed optimal results with no adverse events. The most frequent causes responsible for the onset of such lesions are peripheral arterial catheterization procedures and dopamine extravasation. Our series describe the cardiac arrest as an underestimated cause of onset. Despite the optimal results emerging from the treatment of such lesions with NTG ointment, both in our experience and in the scientific literature, a defined protocol for its use in NICUs is not currently available, hence the need for further studies.
No takes yet. Share an insight, caveat, or question.
Falsaperla et al. (2022) conducted a case report in Ischemic limb lesions (n=3). Nitroglycerine (NTG) ointment was evaluated on Overall outcome and adverse events. Treatment with 2% nitroglycerine ointment yielded optimal results with no adverse events in three preterm neonates with ischemic limb lesions.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: